ResearcherNingbo UniversityActive in the last 2 years

Lei Dai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5742-1963; OpenAlex author ID A5021133988. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers

Papers 3

Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis. Last author DOI 10.1038/s41598-024-79619-1 ↗
Publisher Correction: Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis. Last author DOI 10.1038/s41598-024-81889-8 ↗
Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Co-author DOI 10.1038/s41598-022-16155-w ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lujuan Pan · 2 shared papers, 2024 · strength 0.48
- Paper Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis. DOI 10.1038/s41598-024-79619-1 ↗
- Paper Publisher Correction: Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic … DOI 10.1038/s41598-024-81889-8 ↗
Yang Li · 2 shared papers, 2024 · strength 0.48
- Paper Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis. DOI 10.1038/s41598-024-79619-1 ↗
- Paper Publisher Correction: Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic … DOI 10.1038/s41598-024-81889-8 ↗
Changjiang Lu · 1 shared paper, 2022 · strength 0.20
- Paper Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in h… DOI 10.1038/s41598-022-16155-w ↗
Caide Lu · 1 shared paper, 2022 · strength 0.20
- Paper Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in h… DOI 10.1038/s41598-022-16155-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.